Literature DB >> 16050138

Tumor transition zone: a putative new morphological and functional hallmark of tumor aggressiveness.

Oscar D Bustuoabad1, Raúl A Ruggiero, Pedro di Gianni, M Gabriela Lombardi, Carolina Belli, Gabriela V Camerano, Graciela Dran, Carolina Schere-Levy, Héctor Costa, Martin A Isturiz, Marina Narvaitz, Nico van Rooijen, Victoria de los A Bustuoabad, Roberto P Meiss.   

Abstract

A small primary or secondary tumor load can occasionally induce more deleterious effects than a histologically identical larger one. In the four murine models studied herein this enhanced tumor aggressiveness could not be attributed to NRAS mutations or other hereditary changes, differential vascularization of live tumor tissues, or necrosis content. Instead, the main tumor feature associated with a more aggressive behavior was the presence of a high number of vessels, sometimes filled with inflammatory cells, inside a tumor area, which we have identified and designated as the transition zone between the live and the necrotic zones. Our experiments suggest that during tumor growth, different cachectic factors are produced within the transition and necrotic zones by dying tumor cells and by tumor infiltrating macrophages only reaching the general circulation through the vessels present in the transition zone. Therefore, a small tumor displaying high vascularization of its transition area could be harmful to its host, while, in contrast, a large tumor could behave as a relatively benign one if its transition zone exhibited little or no vascularization, and in consequence its cachectic factors remained "trapped." Similar histological images to those observed in mice were seen in a significant percentage of human cancer biopsies, raising the possibility that such images might have a prognostic value.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050138     DOI: 10.3727/096504005776367933

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  3 in total

1.  B cells inhibit the antitumor immunity against an established murine fibrosarcoma.

Authors:  Andrea Maglioco; Damián G Machuca; María Noel Badano; Paula Nannini; Gabriela V Camerano; Héctor Costa; Roberto Meiss; Raúl A Ruggiero; Mirta Giordano; Graciela I Dran
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

2.  In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis.

Authors:  S Ganai; R B Arenas; J P Sauer; B Bentley; N S Forbes
Journal:  Cancer Gene Ther       Date:  2011-03-25       Impact factor: 5.987

3.  Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation.

Authors:  Paula Chiarella; Mónica Vermeulen; Daniela R Montagna; Pablo Vallecorsa; Ariel Ramiro Strazza; Roberto P Meiss; Oscar D Bustuoabad; Raúl A Ruggiero; Richmond T Prehn
Journal:  Front Oncol       Date:  2018-01-26       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.